Optimal Control of Drug Epidemics

Prevent and Treat--But Not at the Same Time?

Published in: Management Science, v. 46, no. 3, Mar. 2000, p. 333-347

Posted on RAND.org on December 31, 1999

by Doris A. Behrens, Jonathan P. Caulkins, Gernot Tragler, Gustav Feichtinger

Read More

Access further information on this document at mansci.pubs.informs.org

This article was published outside of RAND. The full text of the article can be found at the link above.

Drug use and related problems change substantially over time, so it seems plausible that drug interventions should vary too. To investigate this possibility, the authors set up a continuous time version of the first-order difference equation model of cocaine use introduced by Everingham and Rydell (1994), extended to make initiation an endogenous function of prevalence. They then formulate and solve drug treatment and prevention spending decisions in the framework of dynamic optimal control under different assumptions about how freely drug control budgets can be manipulated. Insights include: (1) The effectiveness of prevention and treatment depend critically on the stage in the epidemic in which they are employed. Prevention is most appropriate when there are relatively few heavy users, e.g. in the beginning of an epidemic. Treatment is more effective later. (2) Hence, the optimal mix of interventions varies over time. (3) The transition period when it is optimal to use extensively both prevention and treatment is brief. (4) Total social costs increase dramatically if control is delayed.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.